Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

Affiliations

• ¹ Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
• ² Division of Hematology and Oncology, University of Washington, Seattle, WA, USA.
• ³ Seattle Children's Therapeutics, Seattle Children's Hospital, Seattle, WA, USA.
• ⁴ Department of Clinical Haematology, Peter MacCallum Cancer Centre, and Royal Melbourne Hospital, Melbourne, VIC, Australia.
• ⁵ Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
• ⁶ Department of Quantitative Health Sciences, Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
• ⁷ Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
• ⁸ The Malignant Haematology, Transplantation and Cellular Therapies Service, Alfred Hospital, Melbourne, VIC, Australia.
• ⁹ Australasia Leukaemia and Lymphoma Group (ALLG), Richmond, VIC, Australia.
• ¹⁰ Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
• ¹¹ Department of Haematology, Northern Hospital, Melbourne, VIC, Australia.
• ¹² Department of Haematology, Eastern Health, Box Hill, VIC, Australia.
• ¹³ Austin Health, Melbourne, VIC, Australia.
• ¹⁴ Eastern Health, Box Hill Hospital and Monash University, Melbourne, VIC, Australia.
• ¹⁵ Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
• ¹⁶ Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
• ¹⁷ Freelance Statistician, Saadati Solutions, Ladenburg, Germany.
• ¹⁸ Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
• ¹⁹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ²⁰ Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
• ²¹ Duke University Cancer Center, Durham, NC, USA.
• ²² Washington University School of Medicine, St. Louis, MO, USA.
• ²³ City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
• ²⁴ University of Chicago, Chicago, IL, USA.
• ²⁵ Centre for Trials Research, Cardiff University, Cardiff, UK.
• ²⁶ Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
• ²⁷ School of Medicine, Nottingham University, Nottingham, UK.
• ²⁸ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
• ²⁹ Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA. mothus@fredhutch.org.
• ³⁰ Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
• ³¹ Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, WA, USA.
• ³² Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.